Intraoperative mitomycin C in the treatment of cicatricial obliterations of conjunctival fornices.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 8909216.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To investigate whether the intraoperative use of topical mitomycin C improved the postoperative outcome in cases of cicatricial obliteration of conjunctival fornices. Ten eyes of five patients were subjected to surgical lysis of the synechiae followed by intraoperative application of 0.4 mg mitomycin C per milliliter of saline for 3 to 5 minutes. After a follow-up period of 12 to 19 months, no recurrence of synechiae was observed, the conjunctival fornices remained open, and conjunctival overgrowths on the cornea did not recur. No adverse effect was observed. Intraoperative application of mitomycin C proved useful in the surgical treatment of cicatricial shrinkage of conjunctival fornices.
Medical subject headings
- Conjunctival Diseases
- Mitomycin
- Nucleic Acid Synthesis Inhibitors
- Pemphigoid, Benign Mucous Membrane